For a long time, the human microbiome was discussed almost only in terms of bacteria. In recent years, researchers have started to pay more attention to another, much smaller but potentially important community living with us: the mycobiome – the collection of fungi that may inhabit the human body.
Although fungi are usually estimated to represent only a very small fraction of the gut microbiome by number, their larger size, complex cell structure and interaction with the immune system suggest that they might have a meaningful role in this ecosystem.
What Is the Mycobiome?
The term mycobiome is generally used for all fungal organisms (yeasts and molds) that may live in and on the human body. These fungi are considered part of the broader microbiome and may form a dynamic ecosystem together with bacteria, viruses and other microorganisms.
In many studies, the human mycobiome has been reported to include genera such as Candida, Malassezia, Saccharomyces, Aspergillus and others. Depending on the context, fungi may behave as:
- commensals (co‑existing without obvious benefit or harm),
- potential mutualists (possibly providing some benefits), or
- opportunistic pathogens (able to cause problems under certain conditions).
The same fungal species might be harmless in one situation and associated with disease in another, which is why researchers are still trying to clarify their exact roles.
Where Might Fungi Live in the Human Body?
Available research suggests that fungal DNA or fungal cells can be detected at several body sites, although the exact composition and stability of these communities are still being investigated. Commonly discussed locations include:
- Gut: Often considered the best‑studied mycobiome site. Even though fungi may represent only a small fraction of the total microbiome, they might still be metabolically and immunologically active.
- Skin: Fungi, especially Malassezia species, are frequently reported on human skin, particularly in oily areas.
- Oral cavity: Yeasts such as Candida are often found in the mouth as part of the normal flora in many individuals.
- Respiratory tract: Fungal material can sometimes be detected in the airways, especially in certain clinical conditions, although it is not always clear which organisms are stable residents and which are transient.
- Urogenital tract: Some studies describe fungi as part of the vaginal and urinary microbiome in at least a subset of people.
Each body site may have its own characteristic fungal profile, influenced by local pH, moisture, oxygen levels, immune activity and interactions with bacteria. However, our understanding of what is “typical” or “healthy” at each site is still incomplete.
How the Mycobiome May Interact With the Gut Microbiome
The mycobiome is not thought to act in isolation. In the gut, fungi and bacteria may influence each other in several ways:
- They can compete for nutrients or produce substances that affect each other’s growth.
- Some fungi may participate in mixed biofilms together with bacteria, forming structured communities on mucosal surfaces.
- Components of fungal cell walls (such as β‑glucans and mannans) are recognized by the immune system and might indirectly shape how the body responds to other microbes as well.
Because of these interactions, changes in the bacterial microbiome (for example due to diet, medication or infection) could potentially influence the mycobiome, and changes in the mycobiome might also affect bacterial communities. The exact cause‑and‑effect relationships are still under active investigation.
The Mycobiome in Health
In people without obvious disease, the mycobiome is often described as relatively stable at the community level, even though individual species may fluctuate over time. Some researchers propose that fungi might:
- help support barrier function at mucosal surfaces,
- contribute to immune education, by providing low‑level stimulation that helps the immune system learn to distinguish between different types of stimuli,
- and take part in metabolic processes, for example in the breakdown of certain dietary components.
At the same time, it is important to emphasize that many of these potential roles are still hypotheses or early findings. What constitutes a “healthy” mycobiome is not yet clearly defined, and more work is needed to understand how fungal communities vary between individuals, ages and lifestyles.
The Mycobiome in Disease
Alterations in the mycobiome – sometimes referred to as fungal dysbiosis – have been reported in a number of conditions. In various studies, differences in fungal composition or diversity have been associated with:
- inflammatory bowel diseases,
- functional gut disorders,
- chronic liver and metabolic diseases,
- allergic conditions and respiratory diseases,
- and certain infections where fungal overgrowth may become clinically relevant.
However, in most cases it is not yet clear whether these fungal changes are a cause, a consequence, a marker of disease, or a combination of these. Many findings come from relatively small or specific patient groups, and results may differ between studies. Because of this, mycobiome research is generally interpreted with caution, and strong conclusions are usually avoided.
How Do Researchers Study the Mycobiome?
Studying the mycobiome can be technically challenging, and methods are still evolving. Common approaches include:
- Culture‑based techniques, where fungi are grown from samples under controlled conditions. This can provide detailed information about certain species but may miss organisms that are difficult to culture.
- DNA‑based methods, such as sequencing of fungal marker regions or broader metagenomic approaches. These techniques can detect a wider range of fungi but are sensitive to contamination and depend on the quality of reference databases.
- Integrated “multi‑omics” strategies, combining microbial data with host immune, metabolic or clinical information to build a more complete picture.
Because each method has limitations, different studies sometimes report different fungal profiles even when looking at similar body sites or conditions. This is one reason why the field is still considered to be in an exploratory phase.
What Might Influence Our Mycobiome?
Several factors are thought to have an impact on the human mycobiome, although the strength and direction of these effects are not always clear. Potential influences include:
- Early life events, such as mode of birth, early feeding and environmental exposures
- Dietary patterns, including overall diversity of the diet and intake of certain nutrients
- Medications, for example antibiotics, antifungals, acid‑suppressing drugs and immunomodulatory treatments
- Immune status, including chronic inflammation, autoimmune conditions and states of immunodeficiency
- Lifestyle and environment, such as hygiene practices, contact with animals, urban versus rural living and occupational exposures
In many cases, these factors may act together and may influence not only which fungi are present, but also their activity and their interactions with bacteria and the host.
Open Questions and Future Directions
The human mycobiome is still a relatively young area of research. Many important questions remain open, for example:
- How much variation in the mycobiome is normal between healthy individuals?
- What exactly characterizes a “balanced” or “resilient” fungal community?
- In which diseases, if any, do mycobiome changes play a direct causal role?
- Could future strategies aim to modulate the mycobiome in a targeted way, and if so, how?
As methods improve and larger, long‑term studies are carried out, our understanding of the mycobiome will likely continue to change. For now, most findings are interpreted as emerging evidence rather than final answers.
Summary – Why the Mycobiome Matters
The human mycobiome represents a small but potentially meaningful part of the complex microbial world associated with the human body. Current research suggests that:
- fungi may be present at multiple body sites,
- they may interact closely with bacteria and the immune system,
- and changes in fungal communities may be associated with various health and disease states.
At the same time, much remains uncertain, and many results are still preliminary. The aim of mycobiome.eu is to follow and explain this developing field in a careful and accessible way, highlighting both what is currently known and what is still under discussion.
Disclaimer
The information on this website is intended for educational and informational purposes only. It summarizes current scientific research and hypotheses about the human mycobiome and does not provide medical advice, diagnosis or treatment. Many of the findings mentioned are preliminary and may change as new evidence becomes available. For any questions or decisions related to your health, please consult a qualified healthcare professional.